Camille L. Bedrosian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 24,078 shares at $14.58 ($351K) on 2025-09-30, disclosed to the SEC on 2025-10-02.
Open-market sale of $351k AMLX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 12,039 | $176K | 50.0% |
| 2 | $14.58 | 12,039 | $176K | 50.0% |
| Total | $14.58 avg | 24,078 | $351K | 100% |
| Filing → |
| AMLX | SELL | 2025-12-03 | $94K | — | Filing → |
| AMLX | SELL | 2025-04-02 | $43K | — | Filing → |
| AMLX | SELL | 2024-12-03 | $30K | — | Filing → |